{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:59:35Z","timestamp":1790283575083,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03447-x","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T21:04:13Z","timestamp":1781039053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Amphotericin B-cholesterol Co-encapsulated Polymeric Nanoparticles in Protein Hydrogel-based Injectable Depot System for Long-acting Drug Delivery"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1421-3838","authenticated-orcid":false,"given":"Sanat Kumar","family":"Dash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6781-4340","authenticated-orcid":false,"given":"Rashmi","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3856-869X","authenticated-orcid":false,"given":"Anil B.","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"3447_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2020.126623","volume":"242","author":"K Huang","year":"2021","unstructured":"Huang K, Zhang B, Shen ZY, Cai X, Liu ZQ, Zheng YG. Enhanced Amphotericin B production by genetically engineered Streptomyces nodosus. Microbiol Res. 2021;242:126623. https:\/\/doi.org\/10.1016\/j.micres.2020.126623.","journal-title":"Microbiol Res"},{"issue":"1","key":"3447_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","volume":"10","author":"FB Cavassin","year":"2021","unstructured":"Cavassin FB, Ba\u00fa-Carneiro JL, Vilas-Boas RR, Queiroz-Telles F. Sixty years of Amphotericin B: an overview of the main antifungal agent used to treat invasive fungal infections. Infect Dis Ther. 2021;10(1):115\u201347. https:\/\/doi.org\/10.1007\/s40121-020-00382-7.","journal-title":"Infect Dis Ther"},{"issue":"11","key":"3447_CR3","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.1021\/acs.molpharmaceut.4c00485","volume":"21","author":"SK Dash","year":"2024","unstructured":"Dash SK, Benival D, Jindal AB. Formulation strategies to overcome Amphotericin B induced toxicity. Mol Pharm. 2024;21(11):5392\u2013412. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c00485.","journal-title":"Mol Pharm"},{"issue":"8","key":"3447_CR4","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1016\/j.xphs.2024.04.031","volume":"113","author":"MM Smith-Craven","year":"2024","unstructured":"Smith-Craven MM, Dening TJ, Basra AK, Hageman MJ. Enhanced dissolution of Amphotericin B through development of amorphous solid dispersions containing polymer and surfactants. J Pharm Sci. 2024;113(8):2454\u201363. https:\/\/doi.org\/10.1016\/j.xphs.2024.04.031.","journal-title":"J Pharm Sci"},{"issue":"23","key":"3447_CR5","doi-asserted-by":"publisher","first-page":"8488","DOI":"10.1021\/ja403255s","volume":"135","author":"BC Wilcock","year":"2013","unstructured":"Wilcock BC, Endo MM, Uno BE, Burke MD. C2\u2019-OH of Amphotericin B plays an important role in binding the primary sterol of human cells but not yeast cells. J Am Chem Soc. 2013;135(23):8488\u201391. https:\/\/doi.org\/10.1021\/ja403255s.","journal-title":"J Am Chem Soc"},{"issue":"24","key":"3447_CR6","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1080\/17435889.2024.2382669","volume":"19","author":"VM da Costa","year":"2024","unstructured":"da Costa VM, Santos TT, Pinto NV, Carneiro G, Fr\u00e9zard F, Marques Borges GS. To heat or not to heat: the impact of temperature on the aggregation state of Amphotericin B in drug delivery systems. Nanomedicine. 2024;19(24):1953\u20136. https:\/\/doi.org\/10.1080\/17435889.2024.2382669.","journal-title":"Nanomedicine"},{"key":"3447_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12030196","author":"YJ Rodriguez","year":"2020","unstructured":"Rodriguez YJ, Quejada LF, Villamil JC, Baena Y, Parra-Giraldo CM, Perez LD. Development of Amphotericin B micellar formulations based on copolymers of Poly(ethylene glycol) and Poly(\u03b5-caprolactone) conjugated with Retinol. Pharmaceutics. 2020. https:\/\/doi.org\/10.3390\/pharmaceutics12030196.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3447_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11847-0","volume":"7","author":"Q Zia","year":"2017","unstructured":"Zia Q, Mohammad O, Rauf MA, Khan W, Zubair S. Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals. Sci Rep. 2017;7(1):11873. https:\/\/doi.org\/10.1038\/s41598-017-11847-0.","journal-title":"Sci Rep"},{"key":"3447_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119813","volume":"589","author":"K Banshoya","year":"2020","unstructured":"Banshoya K, Kaneo Y, Tanaka T, Yamamoto S, Maeda H. Development of an Amphotericin B micellar formulation using cholesterol-conjugated styrene-maleic acid copolymer for enhancement of blood circulation and antifungal selectivity. Int J Pharm. 2020;589:119813. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119813.","journal-title":"Int J Pharm"},{"issue":"6","key":"3447_CR10","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1086\/377279","volume":"37","author":"E Russell","year":"2003","unstructured":"Russell E, Lewis NPW. The solubility ceiling: a rationale for continuous infusion Amphotericin B therapy? Clin Infec Dis. 2003;37(6):871\u20132. https:\/\/doi.org\/10.1086\/377279.","journal-title":"Clin Infec Dis"},{"issue":"3","key":"3447_CR11","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1128\/aac.46.3.834-840.2002","volume":"46","author":"I Bekersky","year":"2002","unstructured":"Bekersky I, Fielding RM, Dressler DE, Lee JW, Buell DN, Walsh TJ. Plasma protein binding of Amphotericin B and pharmacokinetics of bound versus unbound Amphotericin B after administration of intravenous liposomal Amphotericin B (AmBisome) and Amphotericin B deoxycholate. Antimicrob Agents Chemother. 2002;46(3):834\u201340. https:\/\/doi.org\/10.1128\/aac.46.3.834-840.2002.","journal-title":"Antimicrob Agents Chemother"},{"key":"3447_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10040235","author":"L Mehenni","year":"2018","unstructured":"Mehenni L, Lahiani-Skiba M, Ladam G, Hallouard F, Skiba M. Preparation and characterization of spherical amorphous solid dispersion with Amphotericin B. Pharmaceutics. 2018. https:\/\/doi.org\/10.3390\/pharmaceutics10040235.","journal-title":"Pharmaceutics"},{"key":"3447_CR13","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/j.1475-4983.2007.00718.x","volume":"50","author":"SAMJC Leslie","year":"2007","unstructured":"Leslie SAMJC. Removing gold coating from SEM samples. Palaeontology. 2007;50:1459\u201361. https:\/\/doi.org\/10.1111\/j.1475-4983.2007.00718.x.","journal-title":"Palaeontology"},{"key":"3447_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.106697","volume":"106","author":"K Peng","year":"2025","unstructured":"Peng K, Ammar AA, Himawan A, Dai X, Duncan R, Gilmore BF, et al. Amphotericin B PLGA nanoparticles loaded dissolving microneedle patches in treating cutaneous fungal infections. J Drug Deliv Sci Technol. 2025;106:106697. https:\/\/doi.org\/10.1016\/j.jddst.2025.106697.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3447_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104215","volume":"81","author":"KS Prayag","year":"2023","unstructured":"Prayag KS, Paul AT, Ghorui SK, Jindal AB. Preclinical evaluation of quinapyramine sulphate-loaded lipidic nanocarriers for trypanocidal effect against Trypanosoma evansi. J Drug Deliv Sci Technol. 2023;81:104215. https:\/\/doi.org\/10.1016\/j.jddst.2023.104215.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3447_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120820","volume":"605","author":"AR Bhide","year":"2021","unstructured":"Bhide AR, Jindal AB. Fabrication and evaluation of artemether loaded polymeric nanorods obtained by mechanical stretching of nanospheres. Int J Pharm. 2021;605:120820. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120820.","journal-title":"Int J Pharm"},{"issue":"2","key":"3447_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5455\/jrmds.2017526","volume":"5","author":"MMM Shokrzadeh","year":"2017","unstructured":"Shokrzadeh MMM. An overview of the most common methods for assessing cell viability. J Res Med Dent Sci. 2017;5(2):33\u201341.","journal-title":"J Res Med Dent Sci"},{"key":"3447_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.106024","volume":"167","author":"DH Surve","year":"2021","unstructured":"Surve DH, Jindal AB. Development of cationic Isometamidium chloride loaded long-acting lipid nanoformulation: optimization, cellular uptake, pharmacokinetics, biodistribution, and immunohistochemical evaluation. Eur J Pharm Sci. 2021;167:106024. https:\/\/doi.org\/10.1016\/j.ejps.2021.106024.","journal-title":"Eur J Pharm Sci"},{"key":"3447_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137352","author":"N Sanaeifar","year":"2022","unstructured":"Sanaeifar N, M\u00e4der K, Hinderberger D. Macro- and nanoscale effect of Ethanol on Bovine Serum Albumin gelation and Naproxen release. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23137352.","journal-title":"Int J Mol Sci"},{"key":"3447_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25081927","author":"SH Arabi","year":"2020","unstructured":"Arabi SH, Haselberger D, Hinderberger D. The effect of Ethanol on gelation, nanoscopic, and macroscopic properties of Serum Albumin hydrogels. Molecules. 2020. https:\/\/doi.org\/10.3390\/molecules25081927.","journal-title":"Molecules"},{"issue":"5","key":"3447_CR21","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1039\/c8pp00339d","volume":"18","author":"KV Krishna","year":"2019","unstructured":"Krishna KV, Saha RN, Puri A, Viard M, Shapiro BA, Dubey SK. Pre-clinical compartmental pharmacokinetic modeling of 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) as a photosensitizer in rat plasma by validated HPLC method. Photochem Photobiol Sci. 2019;18(5):1056\u201363. https:\/\/doi.org\/10.1039\/c8pp00339d.","journal-title":"Photochem Photobiol Sci"},{"key":"3447_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2025.1594001","volume":"12","author":"L Ding","year":"2025","unstructured":"Ding L, Ferdous Z, Zhang Z, Chen J, Spiegel JL, et al. Porphyrin-based nanotechnology: a minimally invasive approach for drug delivery and cholesteatoma treatment. Front Surg. 2025;12:1594001. https:\/\/doi.org\/10.3389\/fsurg.2025.1594001.","journal-title":"Front Surg"},{"issue":"2","key":"3447_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1369\/0022155417741467","volume":"66","author":"JY Chung","year":"2018","unstructured":"Chung JY, Song JS, Ylaya K, Sears JD, Choi L, Cho H, et al. Histomorphological and molecular assessments of the fixation times comparing Formalin and Ethanol-based fixatives. J Histochem Cytochem. 2018;66(2):121\u201335. https:\/\/doi.org\/10.1369\/0022155417741467.","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"3447_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s13181-010-0120-8","volume":"7","author":"GP Patel","year":"2011","unstructured":"Patel GP, Crank CW, Leikin JB. An evaluation of hepatotoxicity and nephrotoxicity of liposomal amphotericin B (L-AMB). J Med Toxicol. 2011;7(1):12\u20135. https:\/\/doi.org\/10.1007\/s13181-010-0120-8.","journal-title":"J Med Toxicol"},{"issue":"1","key":"3447_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-03027-2","volume":"15","author":"X Liang","year":"2025","unstructured":"Liang X, Wang Q, Lai K, Li X, Gui S, Li Y, et al. Association between aspartate aminotransferase to alanine aminotransferase ratio and mortality in critically ill patients with end stage renal disease. Sci Rep. 2025;15(1):17714. https:\/\/doi.org\/10.1038\/s41598-025-03027-2.","journal-title":"Sci Rep"},{"issue":"1","key":"3447_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-021-02160-w","volume":"21","author":"A Oye-Somefun","year":"2021","unstructured":"Oye-Somefun A, Kuk JL, Ardern CI. Associations between elevated kidney and liver biomarker ratios, metabolic syndrome and all-cause and coronary heart disease (CHD) mortality: analysis of the U.S. National Health and Nutrition Examination Survey (NHANES). BMC Cardiovasc Disord. 2021;21(1):352. https:\/\/doi.org\/10.1186\/s12872-021-02160-w.","journal-title":"BMC Cardiovasc Disord"},{"key":"3447_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2024.100737","volume":"100","author":"S Thakur","year":"2024","unstructured":"Thakur S, Kumar V, Das R, Sharma V, Mehta DK. Biomarkers of hepatic toxicity: an overview. Curr Ther Res Clin Exp. 2024;100:100737. https:\/\/doi.org\/10.1016\/j.curtheres.2024.100737.","journal-title":"Curr Ther Res Clin Exp"},{"issue":"5","key":"3447_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4174\/astr.2015.88.5.281","volume":"88","author":"D Kym","year":"2015","unstructured":"Kym D, Cho YS, Yoon J, Yim H, Yang HT. Evaluation of diagnostic biomarkers for acute kidney injury in major burn patients. Ann Surg Treat Res. 2015;88(5):281\u20138. https:\/\/doi.org\/10.4174\/astr.2015.88.5.281.","journal-title":"Ann Surg Treat Res"},{"issue":"11","key":"3447_CR29","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1128\/aac.03570-14","volume":"58","author":"AC Mesa-Arango","year":"2014","unstructured":"Mesa-Arango AC, Trevijano-Contador N, Rom\u00e1n E, S\u00e1nchez-Fresneda R, Casas C, Herrero E, et al. The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug. Antimicrob Agents Chemother. 2014;58(11):6627\u201338. https:\/\/doi.org\/10.1128\/aac.03570-14.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"3447_CR30","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/jat.4151","volume":"41","author":"SA Alenazi","year":"2021","unstructured":"Alenazi SA, Elmorsy E, Al-Ghafari A, El-Husseini A. Effect of amphotericin B-deoxycholate (Fungizone) on the mitochondria of Wistar rats\u2019 renal proximal tubules cells. J Appl Toxicol. 2021;41(10):1620\u201333. https:\/\/doi.org\/10.1002\/jat.4151.","journal-title":"J Appl Toxicol"},{"key":"3447_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24152744","author":"T Chuacharoen","year":"2019","unstructured":"Chuacharoen T, Prasongsuk S, Sabliov CM. Effect of surfactant concentrations on physicochemical properties and functionality of curcumin nanoemulsions under conditions relevant to commercial utilization. Molecules. 2019. https:\/\/doi.org\/10.3390\/molecules24152744.","journal-title":"Molecules"},{"key":"3447_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24234325","author":"H Luan","year":"2019","unstructured":"Luan H, Gong L, Yue X, Nie X, Chen Q, Guan D, et al. Micellar aggregation behavior of alkylaryl sulfonate surfactants for enhanced oil recovery. Molecules. 2019. https:\/\/doi.org\/10.3390\/molecules24234325.","journal-title":"Molecules"},{"issue":"1","key":"3447_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ajps.2018.08.008","volume":"14","author":"J Cao","year":"2019","unstructured":"Cao J, Choi JS, Oshi MA, Lee J, Hasan N, Kim J, et al. Development of PLGA micro- and nanorods with high capacity of surface ligand conjugation for enhanced targeted delivery. Asian J Pharm Sci. 2019;14(1):86\u201394. https:\/\/doi.org\/10.1016\/j.ajps.2018.08.008.","journal-title":"Asian J Pharm Sci"},{"issue":"10","key":"3447_CR34","first-page":"19670","volume":"8","author":"SB Sun","year":"2015","unstructured":"Sun SB, Liu P, Shao FM, Miao QL. Formulation and evaluation of PLGA nanoparticles loaded Capecitabine for prostate cancer. Int J Clin Exp Med. 2015;8(10):19670\u201381.","journal-title":"Int J Clin Exp Med"},{"key":"3447_CR35","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jconrel.2021.12.019","volume":"341","author":"R Fern\u00e1ndez-Garc\u00eda","year":"2022","unstructured":"Fern\u00e1ndez-Garc\u00eda R, Mu\u00f1oz-Garc\u00eda JC, Wallace M, Fabian L, Gonz\u00e1lez-Burgos E, G\u00f3mez-Serranillos MP, et al. Self-assembling, supramolecular chemistry and pharmacology of Amphotericin B: poly-aggregates, oligomers and monomers. J Control Release. 2022;341:716\u201332. https:\/\/doi.org\/10.1016\/j.jconrel.2021.12.019.","journal-title":"J Control Release"},{"issue":"1","key":"3447_CR36","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2022.2161671","volume":"30","author":"X Zhong","year":"2023","unstructured":"Zhong X, Yang J, Liu H, Yang Z, Luo P. Potential lipid-based strategies of Amphotericin B designed for oral administration in clinical application. Drug Deliv. 2023;30(1):2161671. https:\/\/doi.org\/10.1080\/10717544.2022.2161671.","journal-title":"Drug Deliv"},{"issue":"6","key":"3447_CR37","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1021\/acs.molpharmaceut.0c00313","volume":"17","author":"S Das","year":"2020","unstructured":"Das S, Devarajan PV. Enhancing safety and efficacy by altering the toxic aggregated state of Amphotericin B in lipidic nanoformulations. Mol Pharm. 2020;17(6):2186\u201395. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00313.","journal-title":"Mol Pharm"},{"key":"3447_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29235659","author":"J Wang","year":"2024","unstructured":"Wang J, Wang J, Zheng M, Li D. Effects of different concentrations of AmB on the unsaturated Phospholipid-Cholesterol membrane using the Langmuir Monolayer and liposome models. Molecules. 2024. https:\/\/doi.org\/10.3390\/molecules29235659.","journal-title":"Molecules"},{"key":"3447_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11010100","author":"F Jamal","year":"2023","unstructured":"Jamal F, Altaf I, Ahmed G, Asad S, Ahmad H, Zia Q, et al. Amphotericin B nano-assemblies circumvent intrinsic toxicity and ensure superior protection in experimental visceral leishmaniasis with feeble toxic manifestation. Vaccines. 2023. https:\/\/doi.org\/10.3390\/vaccines11010100.","journal-title":"Vaccines"},{"issue":"7","key":"3447_CR40","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.bios.2006.06.004","volume":"22","author":"S Yilma","year":"2007","unstructured":"Yilma S, Cannon-Sykora J, Samoylov A, Lo T, Liu N, Brinker CJ, et al. Large-conductance cholesterol-Amphotericin B channels in reconstituted lipid bilayers. Biosens Bioelectron. 2007;22(7):1359\u201367. https:\/\/doi.org\/10.1016\/j.bios.2006.06.004.","journal-title":"Biosens Bioelectron"},{"key":"3447_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/nano10061152","author":"M Saqib","year":"2020","unstructured":"Saqib M, Ali Bhatti AS, Ahmad NM, Ahmed N, Shahnaz G, Lebaz N, et al. Amphotericin B loaded polymeric nanoparticles for treatment of Leishmania infections. Nanomaterials. 2020. https:\/\/doi.org\/10.3390\/nano10061152.","journal-title":"Nanomaterials"},{"issue":"24","key":"3447_CR42","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1007\/s00018-019-03154-w","volume":"76","author":"A Wu","year":"2019","unstructured":"Wu A, Grela E, W\u00f3jtowicz K, Filipczak N, Hamon Y, Luchowski R, et al. ABCA1 transporter reduces amphotericin B cytotoxicity in mammalian cells. Cell Mol Life Sci. 2019;76(24):4979\u201394. https:\/\/doi.org\/10.1007\/s00018-019-03154-w.","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"3447_CR43","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.1039\/d0cs01127d","volume":"50","author":"M Sousa de Almeida","year":"2021","unstructured":"Sousa de Almeida M, Susnik E, Drasler B, Taladriz-Blanco P, Petri-Fink A, Rothen-Rutishauser B. Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine. Chem Soc Rev. 2021;50(9):5397\u2013434. https:\/\/doi.org\/10.1039\/d0cs01127d.","journal-title":"Chem Soc Rev"},{"key":"3447_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17101355","author":"S Jacob","year":"2025","unstructured":"Jacob S, Kather FS, Satyam SM, Boddu SHS, Assaf F, Allam THA, et al. Injectable in situ thermoreversible gel depot system of Lidocaine nanoemulsion for prolonged anesthetic activity in dental and operative procedures. Pharmaceutics. 2025. https:\/\/doi.org\/10.3390\/pharmaceutics17101355.","journal-title":"Pharmaceutics"},{"key":"3447_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13060864","author":"NW Kang","year":"2021","unstructured":"Kang NW, Yoon SY, Kim S, Yu NY, Park JH, Lee JY, et al. Subcutaneously injectable Hyaluronic Acid hydrogel for sustained release of Donepezil with reduced initial burst release: effect of hybridization of microstructured lipid carriers and albumin. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13060864.","journal-title":"Pharmaceutics"},{"issue":"28","key":"3447_CR46","doi-asserted-by":"publisher","first-page":"17531","DOI":"10.1021\/acsomega.0c02009","volume":"5","author":"K Dutta","year":"2020","unstructured":"Dutta K, Das R, Ling J, Monibas RM, Carballo-Jane E, Kekec A, et al. In situ forming injectable thermoresponsive hydrogels for controlled delivery of biomacromolecules. ACS Omega. 2020;5(28):17531\u201342. https:\/\/doi.org\/10.1021\/acsomega.0c02009.","journal-title":"ACS Omega"},{"issue":"3","key":"3447_CR47","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/088391159200700303","volume":"7","author":"WSCM Shalaby","year":"1992","unstructured":"Shalaby WSCM, Park K. A mechanistic assessment of enzyme-induced degradation of albumin-crosslinked hydrogels. J Bioact Compat Polym. 1992;7(3):257\u201374. https:\/\/doi.org\/10.1177\/088391159200700303.","journal-title":"J Bioact Compat Polym"},{"issue":"1","key":"3447_CR48","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1166\/jbn.2011.1230","volume":"7","author":"RK Verma","year":"2011","unstructured":"Verma RK, Pandya S, Misra A. Loading and release of amphotericin-B from biodegradable poly(lactic-co-glycolic acid) nanoparticles. J Biomed Nanotechnol. 2011;7(1):118\u201320. https:\/\/doi.org\/10.1166\/jbn.2011.1230.","journal-title":"J Biomed Nanotechnol"},{"key":"3447_CR49","doi-asserted-by":"publisher","first-page":"6945","DOI":"10.2147\/ijn.S467876","volume":"19","author":"N Qu","year":"2024","unstructured":"Qu N, Song K, Ji Y, Liu M, Chen L, Lee RJ, et al. Albumin Nanoparticle-Based Drug Delivery Systems. Int J Nanomedicine. 2024;19:6945\u201380. https:\/\/doi.org\/10.2147\/ijn.S467876.","journal-title":"Int J Nanomedicine"},{"key":"3447_CR50","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.addr.2018.03.007","volume":"127","author":"R Dimatteo","year":"2018","unstructured":"Dimatteo R, Darling NJ, Segura T. In situ forming injectable hydrogels for drug delivery and wound repair. Adv Drug Deliv Rev. 2018;127:167\u201384. https:\/\/doi.org\/10.1016\/j.addr.2018.03.007.","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"3447_CR51","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1016\/j.apsb.2021.05.002","volume":"11","author":"Y Shi","year":"2021","unstructured":"Shi Y, Lu A, Wang X, Belhadj Z, Wang J, Zhang Q. A review of existing strategies for designing long-acting parenteral formulations: focus on underlying mechanisms, and future perspectives. Acta Pharm Sin B. 2021;11(8):2396\u2013415. https:\/\/doi.org\/10.1016\/j.apsb.2021.05.002.","journal-title":"Acta Pharm Sin B"},{"key":"3447_CR52","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.colsurfb.2013.12.041","volume":"116","author":"H Yin","year":"2014","unstructured":"Yin H, Kang HC, Huh KM, Bae YH. Effects of cholesterol incorporation on the physicochemical, colloidal, and biological characteristics of pH-sensitive AB\u2082 miktoarm polymer-based polymersomes. Colloids Surf B Biointerfaces. 2014;116:128\u201337. https:\/\/doi.org\/10.1016\/j.colsurfb.2013.12.041.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"6","key":"3447_CR53","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1021\/acsami.7b16891","volume":"10","author":"L Liang","year":"2018","unstructured":"Liang L, Fu J, Qiu L. Design of pH-sensitive nanovesicles via cholesterol analogue incorporation for improving in vivo delivery of chemotherapeutics. ACS Appl Mater Interfaces. 2018;10(6):5213\u201326. https:\/\/doi.org\/10.1021\/acsami.7b16891.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"2","key":"3447_CR54","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1208\/s12248-011-9267-8","volume":"13","author":"L Kagan","year":"2011","unstructured":"Kagan L, Gershkovich P, Wasan KM, Mager DE. Physiologically based pharmacokinetic model of amphotericin B disposition in rats following administration of deoxycholate formulation (Fungizone\u00ae): pooled analysis of published data. AAPS J. 2011;13(2):255\u201364. https:\/\/doi.org\/10.1208\/s12248-011-9267-8.","journal-title":"AAPS J"},{"issue":"12","key":"3447_CR55","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1093\/jac\/dkq358","volume":"65","author":"P Gershkovich","year":"2010","unstructured":"Gershkovich P, Sivak O, Wasan EK, Magil AB, Owen D, Clement JG, et al. Biodistribution and tissue toxicity of amphotericin B in mice following multiple dose administration of a novel oral lipid-based formulation (iCo-009). J Antimicrob Chemother. 2010;65(12):2610\u20133. https:\/\/doi.org\/10.1093\/jac\/dkq358.","journal-title":"J Antimicrob Chemother"},{"key":"3447_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011182","author":"CF Adhipandito","year":"2021","unstructured":"Adhipandito CF, Cheung SH, Lin YH, Wu SH. Atypical renal clearance of nanoparticles larger than the kidney filtration threshold. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222011182.","journal-title":"Int J Mol Sci"},{"key":"3447_CR57","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jconrel.2020.05.026","volume":"324","author":"Y Liu","year":"2020","unstructured":"Liu Y, Han Y, Fang T, Chen S-M, Hu X, Song L, et al. Turning weakness into strength: albumin nanoparticle-redirected amphotericin B biodistribution for reducing nephrotoxicity and enhancing antifungal activity. J Control Release. 2020;324:657\u201368. https:\/\/doi.org\/10.1016\/j.jconrel.2020.05.026.","journal-title":"J Control Release"},{"key":"3447_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114862","volume":"198","author":"AB Jindal","year":"2023","unstructured":"Jindal AB, Bhide AR, Salave S, Rana D, Benival D. Long-acting parenteral drug delivery systems for the treatment of chronic diseases. Adv Drug Deliv Rev. 2023;198:114862. https:\/\/doi.org\/10.1016\/j.addr.2023.114862.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"3447_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-87750-w","volume":"15","author":"W Pula","year":"2025","unstructured":"Pula W, Pepe A, Ferrara F, Bondi A, Mariani P, Ortore MG, et al. In situ forming gels as subcutaneous delivery systems of curcumin and piperine. Sci Rep. 2025;15(1):3046. https:\/\/doi.org\/10.1038\/s41598-025-87750-w.","journal-title":"Sci Rep"},{"issue":"13-14","key":"3447_CR60","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1089\/ten.TEA.2020.0124","volume":"27","author":"SV Gohil","year":"2021","unstructured":"Gohil SV, Padmanabhan A, Kan HM, Khanal M, Nair LS. Degradation-dependent protein release from enzyme sensitive injectable Glycol Chitosan hydrogel. Tissue Eng Part A. 2021;27(13\u201314):867\u201380. https:\/\/doi.org\/10.1089\/ten.TEA.2020.0124.","journal-title":"Tissue Eng Part A"},{"issue":"1","key":"3447_CR61","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-025-01171-1","volume":"28","author":"DA Silva","year":"2025","unstructured":"Silva DA, Le Merdy M, Mullin J, Malavia N, Alam K, Tsakalozou E, et al. Mechanistic modeling of intramuscular administration of a long-acting injectable accounting for tissue response at the depot site. AAPS J. 2025;28(1):4. https:\/\/doi.org\/10.1208\/s12248-025-01171-1.","journal-title":"AAPS J"},{"key":"3447_CR62","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jconrel.2016.03.041","volume":"230","author":"N Darville","year":"2016","unstructured":"Darville N, van Heerden M, Mari\u00ebn D, De Meulder M, Rossenu S, Vermeulen A, et al. The effect of macrophage and angiogenesis inhibition on the drug release and absorption from an intramuscular sustained-release paliperidone palmitate suspension. J Control Release. 2016;230:95\u2013108. https:\/\/doi.org\/10.1016\/j.jconrel.2016.03.041.","journal-title":"J Control Release"},{"issue":"50","key":"3447_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201805557","volume":"30","author":"W Zhang","year":"2018","unstructured":"Zhang W, Wang M, Tang W, Wen R, Zhou S, Lee C, et al. Nanoparticle-laden macrophages for tumor-tropic drug delivery. Adv Mater. 2018;30(50):e1805557. https:\/\/doi.org\/10.1002\/adma.201805557.","journal-title":"Adv Mater"},{"issue":"4","key":"3447_CR64","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","volume":"10","author":"HH Gustafson","year":"2015","unstructured":"Gustafson HH, Holt-Casper D, Grainger DW, Ghandehari H. Nanoparticle uptake: the phagocyte problem. Nano Today. 2015;10(4):487\u2013510. https:\/\/doi.org\/10.1016\/j.nantod.2015.06.006.","journal-title":"Nano Today"},{"issue":"1","key":"3447_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9692","volume":"6","author":"MA Miller","year":"2015","unstructured":"Miller MA, Zheng Y-R, Gadde S, Pfirschke C, Zope H, Engblom C, et al. Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug. Nat Commun. 2015;6(1):8692. https:\/\/doi.org\/10.1038\/ncomms9692.","journal-title":"Nat Commun"},{"issue":"Suppl 1","key":"3447_CR66","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/milmed\/usz248","volume":"185","author":"AH Scultetus","year":"2020","unstructured":"Scultetus AH, Jefferson MA, Haque A, Hubbell JN, Arnaud FG, Moon-Massat P, et al. Histopathological evidence of multiple organ damage after simulated aeromedical evacuation in a swine acute lung injury model. Mil Med. 2020;185(Suppl 1):57\u201366. https:\/\/doi.org\/10.1093\/milmed\/usz248.","journal-title":"Mil Med"},{"issue":"7","key":"3447_CR67","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16445","volume":"13","author":"V Gursoy","year":"2021","unstructured":"Gursoy V, Ozkalemkas F, Ozkocaman V, Serenli Yegen Z, Ethem Pinar I, Ener B, et al. Conventional amphotericin B associated nephrotoxicity in patients with hematologic malignancies. Cureus. 2021;13(7):e16445. https:\/\/doi.org\/10.7759\/cureus.16445.","journal-title":"Cureus"},{"key":"3447_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110297","volume":"128","author":"K Kaur","year":"2020","unstructured":"Kaur K, Kumar P, Kush P. Amphotericin B loaded ethyl cellulose nanoparticles with magnified oral bioavailability for safe and effective treatment of fungal infection. Biomed Pharmacother. 2020;128:110297. https:\/\/doi.org\/10.1016\/j.biopha.2020.110297.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"3447_CR69","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1016\/j.apsb.2021.04.010","volume":"11","author":"X Wang","year":"2021","unstructured":"Wang X, Mohammad IS, Fan L, Zhao Z, Nurunnabi M, Sallam MA, et al. Delivery strategies of amphotericin B for invasive fungal infections. Acta Pharm Sin B. 2021;11(8):2585\u2013604. https:\/\/doi.org\/10.1016\/j.apsb.2021.04.010.","journal-title":"Acta Pharm Sin B"},{"issue":"1\u20132","key":"3447_CR70","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijpharm.2017.01.011","volume":"519","author":"HB Ruttala","year":"2017","unstructured":"Ruttala HB, Ramasamy T, Shin BS, Choi HG, Yong CS, Kim JO. Layer-by-layer assembly of hierarchical nanoarchitectures to enhance the systemic performance of nanoparticle albumin-bound paclitaxel. Int J Pharm. 2017;519(1\u20132):11\u201321. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.01.011.","journal-title":"Int J Pharm"},{"key":"3447_CR71","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/360438","volume":"2014","author":"A Ayala","year":"2014","unstructured":"Ayala A, Mu\u00f1oz MF, Arg\u00fcelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014:360438. https:\/\/doi.org\/10.1155\/2014\/360438.","journal-title":"Oxid Med Cell Longev"},{"key":"3447_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2021.108941","volume":"709","author":"C Mas-Bargues","year":"2021","unstructured":"Mas-Bargues C, Escriv\u00e1 C, Dromant M, Borr\u00e1s C, Vi\u00f1a J. Lipid peroxidation as measured by chromatographic determination of malondialdehyde. human plasma reference values in health and disease. Arch Biochem Biophys. 2021;709:108941. https:\/\/doi.org\/10.1016\/j.abb.2021.108941.","journal-title":"Arch Biochem Biophys"},{"issue":"1\u20132","key":"3447_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2008.08.006","volume":"30","author":"HJ Forman","year":"2009","unstructured":"Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009;30(1\u20132):1\u201312. https:\/\/doi.org\/10.1016\/j.mam.2008.08.006.","journal-title":"Mol Aspects Med"},{"issue":"10","key":"3447_CR74","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/cdd.2009.107","volume":"16","author":"R Franco","year":"2009","unstructured":"Franco R, Cidlowski JA. Apoptosis and glutathione: beyond an antioxidant. Cell Death Differ. 2009;16(10):1303\u201314. https:\/\/doi.org\/10.1038\/cdd.2009.107.","journal-title":"Cell Death Differ"},{"issue":"2","key":"3447_CR75","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0009-2797(94)03591-u","volume":"96","author":"GL Squadrito","year":"1995","unstructured":"Squadrito GL, Pryor WA. The formation of peroxynitrite in vivo from nitric oxide and superoxide. Chem Biol Interact. 1995;96(2):203\u20136. https:\/\/doi.org\/10.1016\/0009-2797(94)03591-u.","journal-title":"Chem Biol Interact"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03447-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03447-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03447-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:04:22Z","timestamp":1790280262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03447-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":75,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["3447"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03447-x","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We have nothing to declare.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"234"}}